To investigate nutritional status and body composition in different ages of maintaining hemodialysis (HD) patients. 129 patients (male 62, female 67) with the mean age 56.33714.14 years on HD were divided into four groups with age under 40, 40-69, 60-69 and over 70 years. Body composition was evaluated with Multi-frequency bioelectric impedance analysis (BIA) and 83 healthy subjects, matched for age and sex, were as the control. In all patients, about 6.2% were underweight with body mass index (BMI) less than 18.5 Kg/ m 2 . The incidence of underweight were 0%, 6.2%, 4.8% and 11.1% in groups under 40, 40-59, 60-69 and over 70 years respectively. Serum Creatinine, ALB, pre-ALB and normalized protein catabolic rate (nPCR) were significantly decreased in patients over 70 years. The young patients under 40 years also displayed lower nPCR and CHO value compared with that of group 40-59 years. Body cell mass, lean tissue mass, lean tissue index and relative lean tissue mass in HD patients were significantly lower than that in age and sex matched control group. Meanwhile, fat mass, fat tissue index and relative fat were increase 20% than the control. They were less different between HD patients and controls in age of 40-59 years, however, difference significantly increased
in other three groups and changes were most obvious in patients over 70 years. In conclusion, our study showed that nutritional status was significantly associated with the age in HD patients. Patients under 40 years and over 70 years old displayed much severer protein wasting and more fat tissue storage. Bioimpedance spectroscopy with body composition model is a validated method to assess hydration and nutritional status in dialysis patients. The aim of this study is to compare quality of life, nutrition status and hydration status between hemodialysis and peritoneal dialysis patients. There were 26 PD and 32 HD patients included in this study. Multifrequency bioimpedance spectroscopy were measured by BCM-body composition monitor (Fresenius medical care) device, the device provided body composition parameters including Lean Tissue index (LTI) Fat tissue index (FTI) and quantified over hydration status (OH). Quality of life was measured by WHO-QOL-BREF questionnaire. Scheffe's test was used for comparison and p o0.05 was considered as statistically significant. All of the PD patients had weekly Kt/V 41.7 and all of the HD patients had weekly Kt/V 43.6. There were no differences in Charlson's comobidity index, food intake, protein intake, BMI, blood pressure and quality of life between groups. LTI and FTI between PD (12.26 þ3.65, 10.79 þ5.84) and HD (11.48 þ3.48, 10.52 þ4.67) patients were not statistically different. PD patients had more over hydration when compare to HD patients (16.18 þ11.24 vs. 2.36 þ 11.07%OH/ECW po 0.0001) and ECW to ICW ratio was higher in PD patients (1.02 þ0.21 vs. 0.89 þ0.18 p¼0.035). Hypokalemia is a significant problem in CAPD patients. The impact of hypokalemia on treatment outcome was not known. The study objective was to compare the nutritional status as measured by Multifrequency bioimpedance spectroscopy (BIS) and quality of life between peritoneal dialysis patients who has hypokalemia and normokalemia. There were 8 hypokalemic and 18 normokalemic PD patients in this study. BIS were measured by BCM-body composition monitor (Fresenius medical care) device, quality of life was measured by WHOQOL-BREF questionnaire. Levene's Test was used for comparison and po 0.05 was considered as statistically significant. There was no difference in the co-morbidity, dialysis adequacy, blood pressure and food intake between groups. The quality of life between groups was not statistically difference. BIS showed comparable lean tissue index (LTI), fat tissue index (FTI), urea distribution volume and ECW/ICF water ratio. Patients in the normokalemic group had a non-significant higher percent OH/ECW than hypokalemic group.
Parameters

Hypokalemic Normokalemic p-value In conclusion, nutritional status and quality of life were not statistically different between CAPD patients who had hypokalemia or normokalemia. http://dx.doi.org/10.1016/j.krcp.2012.04.603 280 FAVORED SERUM ALBUMIN LEVEL AND ICF VOLUME AFTER USE OF 1.1% AMINOACID BASED PERITONEAL DIALYSIS(PD) SOLUTION Jong-woo Yoon, Myung-jin Choi, Ja-ryong Koo, Young-ki Lee, Jung-woo Noh Hallym university hospital, Chuncheon, Gangwon-do, South Korea.
Aminoacid based PD solution (AAD) has been shown to induce positive nitrogen balance and improve nutritional markers of malnourished patients. But its effcets on body fluid composition and various nutritional markers are contradictory. Nutritional markers may influenced by patient's ECF volume status. So we evaluate effects of AAD on nutritional markers and body composition by analysis using multi-frequency bioimpedance analyzer. 35 PD patients( 46months duration of CAPD) were prospectively randomized to 17 AAD(Nutrineal, one time use/day) and 18 GD group(keep their glucose based PD solution). After 3 months follow up, AAD group showed marginally increased body weight and fat mass, decreased ECF volume(12.45 7 0.54L vs 12.10 70.57L, p ¼ 0.06), no changed ICF volume(22.2 70.9L vs 22.3 7 0.9L, p 40.05) and marginally increased drainage volume(8.777 0.76L vs 9.12 7 0.83L, p ¼0.09). AAD group also showed favored several markers include nPCR(1.59 70.07 vs 1.98 7 0.08, p ¼0.00), BUN and albumin level (3.54 70.11 vs 3.74 70.11, p ¼0.02). Although serum albumin level was increased, correction with ECF volume(albumin level X ECF volume) makes it no difference (43.457 2.13 vs 44.80 7 2.28, p ¼0.14). Furthermore Walbumin vs WECF showed negative correlation pattern(r ¼-0.46, p ¼ 0.07) that means serum albumin change was influenced by ECF volume change. In conclusion, AAD treatment improved markers of better nutritional status. However the change in serum albumin level was influenced by patient's ECF volume status, which can partially explain contradictory effect of aminoacid based PD solution on serum albumin level.
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